Restricted accessResearch articleFirst published online 2019-9
Effects of Smoking Cessation with Nicotine Replacement Therapy on Vascular Endothelial Function,Arterial Stiffness,and Inflammation Response in Healthy Smokers
The effects of nicotine replacement therapy (NRT)-aided smoking cessation on vascular function are not fully clarified. We investigated 100 healthy smokers who were motivated to quit and received NRT for a 3-month period. Vascular endothelial function (measured by reactive hyperemia-peripheral arterial tonometry [RH-PAT]), arterial stiffness (measured by augmentation index [AI] and brachial-ankle pulse wave velocity [baPWV]), and systemic inflammation markers (including serum soluble intercellular adhesion molecule-1 [sICAM-1] and interleukin-1β [IL-1β]) were assessed at baseline and 3 and 12 months of follow-up. After 3 months of intervention, endothelial function, arterial stiffness, and inflammatory markers significantly improved (RH-PAT increased, AI and baPWV decreased, sICAM-1 and IL-1β decreased, all P < .05) for the participants who abstained from smoking completely, but for those who did not abstained completely, RH-PAT, AI, baPWV, and IL-1β remained unchanged. At 12 months follow-up, endothelial function (RH-PAT), arterial stiffness (AI and baPWV), and inflammatory markers (sICAM-1 and IL-1β) were further improved in participants who abstained from smoking (P < .001), while the above parameters deteriorated in continued smokers (P < .05). In conclusion, vascular dysfunction can be reversible after NRT-aided smoking cessation in healthy smokers and vascular function could be further damaged if they continue smoking.
UeshimaHChoudhurySROkayamaAet al.Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke. 2004;35(8):1836–41.
2.
MannamiTIsoHBabaSSasakiSet al.Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: The JPHC Study Cohort I. Stroke. 2004;35(6):1248–53.
3.
AmbroseJABaruaRS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–37.
4.
KatsikiNPapadopoulouSKFachantidouAIMikhailidisDP. Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease?Public Health. 2013;127(5):435–441.
5.
ArabiZ. Metabolic and cardiovascular effects of smokeless tobacco. J Cardiometab Syndr. 2006;1(5):345–350.
6.
BolinderGAlfredssonLEnglundAet al.Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1996;84(3):399–404.
7.
AmatoMFrigerioBCastelnuovoSet al.Effects of smoking regular or light cigarettes on brachial artery flow mediated dilation. Atherosclerosis. 2013;228(1):153–160.
8.
CelermajerDSAdamsMRClarksonPet al.Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334(3):150–54.
9.
CelermajerDSSorensenKEGeorgakopoulosDet al.Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium dependent dilatation in healthy young adults. Circulation. 1993;88(5 Pt 1):2149–55.
10.
InoueTNodeK. Vascular failure: a new clinical entity for vascular disease. J Hypertens. 2006;24(11):2121–30.
11.
DollRPetoRWheatleyKet al.Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ. 1994;309(6959):901–911.
12.
FreundKMBelangerAJD’AgostinoRBet al.The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol. 1993;3(4):417–424.
13.
GoASMozaffarianDRogerVLet al.Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–292.
14.
Laniado-LaborínR. Smoking cessation intervention: an evidence-based approach. Postgrad Med. 2010;122(2):74–82.
15.
CahillKStevensSPereraRet al.Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;(5):CD009329.
16.
RaitakariOTAdamsMRMcCredieRJet al.Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med. 1999;130(7):578–81.
17.
AdamopoulosDvan de BornePArgachaJF. New insights into the sympathetic, endothelial and coronary effects of nicotine. Clin Exp Pharmacol Physiol. 2008;35(4):458–63.
18.
MandraffinoGAragonaCOScuruchiMet al.Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. Atherosclerosis. 2017;257:109–115.
19.
IkonomidisITzortzisSAndreadouIet al.Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circ Cardiovasc Imaging. 2014;7(4):619–628.
20.
IgnarroLJCirinoGCasiniAet al.Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol. 1999;34(6):879–886.
21.
BlacheDBouthillierDDavignonJ. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis. 1992;93(3):179–188.
22.
QuyyumiAA. Prognostic value of endothelial function. Am J Cardiol. 2003;91(12A):19H–24H.
23.
MahEPeiRGuoYet al.Greater γ-tocopherol status during acute smoking abstinence with nicotine replacement therapy improved vascular endothelial function by decreasing 8-iso-15(S)-prostaglandin F2α. Exp Biol Med (Maywood). 2015;240(4):527–33.
24.
JohnsonHMGossettLKPiperMEet al.Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol. 2010;55(18):1988–95.
25.
IkonomidisIMarinouMVlastosDet al.Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. Atherosclerosis. 2017;262:123–30.
26.
BonettiPOLardiEGeissmannCet al.Effect of brief secondhand smoke exposure on endothelial function and circulating markers of inflammation. Atherosclerosis. 2011;215(1):218–22.
27.
SugiuraTDohiYYamashitaSet al.Circulating level of microRNA-126 may be a potential biomarker for recovery from smoking-related vascular damage in middle-aged habitual smokers. Int J Cardiol Heart Vasc. 2015;7:83–87.
28.
PalomboCKozakovaM. Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol. 2016;77:1–7.
29.
van PopeleNMGrobbeeDEBotsMLet al.Association between arterial stiffness and atherosclerosis. the Rotterdam Study. Stroke. 2001;32(2):454–60.
30.
ZureikMBureauJMTemmarMet al.Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension. 2003;41(3):519–27.
31.
VlachopoulosCAznaouridisKBratsasAet al.Arterial stiffening and systemic endothelial activation induced by smoking: The role of COX-1 and COX-2. Int J Cardiol. 2015;189:293–98.
32.
VlachopoulosCKosmopoulouFPanagiotakosDet al.Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. J Am Coll Cardiol. 2004;44(9):1911–17.
33.
van den BerkmortelFWWollersheimHvan LangenHet al.Two years of smoking cessation does not reduce arterial wall thickness and stiffness. Neth J Med. 2004;62(7):235–41.
34.
Yu-JieWHui-LiangLBingLet al.Impact of smoking and smoking cessation on arterial stiffness in healthy participants. Angiology. 2013;64(4):273–80.
35.
IkonomidisITzortzisSPapaioannouTet al.Incremental value of arterial wave reflections in the determination of left ventricular diastolic dysfunction in untreated patients with essential hypertension. J Hum Hypertens. 2008;22(10):687–98.
36.
FröhlichMSundMLöwelHet al.Independent association of various smoking characteristics with markers of systemic inflammation in men: Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24(14):1365–72.
37.
CavusogluYTimuralpBUsTet al.Cigarette smoking increases plasma concentrations of vascular cell adhesion molecule-1 in patients with coronary artery disease. Angiology. 2004;55(4):397–402.
38.
IkonomidisILekakisJVamvakouGet al.Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J. 2005;149(5):832–39.
39.
KuschnerWGD’AlessandroAWongHet al.Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996;9(10):1989–94.
40.
EbersoleJLSteffenMJThomasMet al.Smoking-related cotinine levels and host responses in chronic periodontitis. J Periodontal Res. 2014;49(5):642–51.
41.
NordskogBKBrownBGMaranoKMet al.Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect. Inhal Toxicol. 2015;27(3):157–66.
